Montag & Associates’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-40,000
| Closed | -$81K | – | 950 |
|
|
2022
Q3 | $81K | Hold |
40,000
| – | – | 0.01% | 465 |
|
|
2022
Q2 | $127K | Hold |
40,000
| – | – | 0.01% | 415 |
|
|
2022
Q1 | $167K | Hold |
40,000
| – | – | 0.01% | 410 |
|
|
2021
Q4 | $192K | Hold |
40,000
| – | – | 0.01% | 389 |
|
|
2021
Q3 | $214K | Hold |
40,000
| – | – | 0.01% | 375 |
|
|
2021
Q2 | $205K | Hold |
40,000
| – | – | 0.01% | 382 |
|
|
2021
Q1 | $269K | Hold |
40,000
| – | – | 0.02% | 347 |
|
|
2020
Q4 | $183K | Hold |
40,000
| – | – | 0.01% | 374 |
|
|
2020
Q3 | $155K | Hold |
40,000
| – | – | 0.01% | 297 |
|
|
2020
Q2 | $190K | Hold |
40,000
| – | – | 0.02% | 286 |
|
|
2020
Q1 | $139K | Hold |
40,000
| – | – | 0.01% | 273 |
|
|
2019
Q4 | $193K | Buy |
+40,000
| New | +$193K | 0.02% | 297 |
|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$72K | – | 302 |
|
|
2019
Q2 | $72K | Hold |
10,000
| – | – | 0.01% | 304 |
|
|
2019
Q1 | $142K | Hold |
10,000
| – | – | 0.01% | 300 |
|
|
2018
Q4 | $135K | Hold |
10,000
| – | – | 0.01% | 280 |
|
|
2018
Q3 | $222K | Hold |
10,000
| – | – | 0.02% | 301 |
|
|
2018
Q2 | $164K | Buy |
+10,000
| New | +$164K | 0.02% | 273 |
|